Coronavirus Update: J&J says booster greatly improves COVID-19 vaccine efficacy as experts await FDA decisionMarket Watch • 09/21/21
J&J's vaccine works as well as the Pfizer or Moderna shots after a second dose, study saysBusiness Insider • 09/21/21
Coronavirus tally: Global cases of COVID-19 top 229 million and J&J says booster vaccine shot increases antibodiesMarket Watch • 09/21/21
Johnson & Johnson says Phase 3 trial data confirms 'strong and long-lasting' protection from COVID-19 vaccineMarket Watch • 09/21/21
J&J says Covid booster shot is 94% effective in the U.S. when given two months after first doseCNBC • 09/21/21
Johnson & Johnson Announces Real-World Evidence and Phase 3 Data Confirming Strong and Long-Lasting Protection of Single-Shot COVID-19 Vaccine in the U.S.PRNewsWire • 09/21/21
Week 38 MDA Breakout Stocks - September 2021: Short-Term Picks To Give You An EdgeSeeking Alpha • 09/19/21
Johnson & Johnson (JNJ) Management Presents on Morgan Stanley 19th Annual Global Healthcare Conference (Transcript)Seeking Alpha • 09/15/21